Studying why some heart failure patients respond better to treatment
Observational study collecting samples from adults with heart failure to find biomarkers.
Plain-language title generated from the registry record
Registry title: Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
Key facts
- Where
- Stockholm, SwedenSee the site
Where in Sweden
- Karolinska University HospitalStockholm, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Karolinska University Hospital
- Trial code
- NCT06435585
- Record updated
- 10 August 2026
- Original description
A biobank within the Swedish national heart failure quality registry SwedeHF.Read full original descriptionShow less
Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
A biobank within the Swedish national heart failure quality registry SwedeHF.
Inclusion: Written informed consent; Heart failure defined by symptoms and signs of heart failure as judged by the local investigator; Registered in SwedeHF.
Exclusion: Plasma donation within 1 month of enrolment or any blood donation/blood loss >500 mL during the 3 months prior to enrolment; Previous allogeneic bone marrow transplant (genetics); In the opinion of the investigator, condition/s that may either put the patient at risk on participation or influence the results or the patient's ability to participate in the study.